BI
GSK icon

Binnacle Investments’s GSK GSK Stock Holding History

Binnacle Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.9K Buy
392
+109
+39% +$4.26K 0.01% 312
2025
Q2 		$10.9K Buy
283
+73
+35% +$2.79K 0.01% 358
2025
Q1 		$8.14K Buy
+210
New +$7.69K 0.01% 363

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Binnacle Investments's GSK Position: Q3 2025 in Review

Binnacle Investments increased its GSK (GSK) stake by 39% in Q3 2025, buying an estimated $4.26K and bringing the position to 392 shares worth $16.9K. The position accounts for 0.01% of the portfolio, ranked #312.

Binnacle Investments first reported a position in GSK in Q1 2025 and has held it in 3 quarters since. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Binnacle Investments held 392 shares of GSK worth $16.9K as of Q3 2025.
  • Binnacle Investments bought 109 GSK shares in Q3 2025, an estimated $4.26K.
  • GSK made up 0.01% of Binnacle Investments's portfolio in Q3 2025, its #312 holding.
  • Binnacle Investments first reported a position in GSK in Q1 2025 and has held it in 3 quarters since.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.